U.S. Markets closed
  • S&P 500

    3,271.03
    -119.65 (-3.53%)
     
  • Dow 30

    26,519.95
    -943.24 (-3.43%)
     
  • Nasdaq

    11,004.87
    -426.53 (-3.73%)
     
  • Russell 2000

    1,543.28
    -47.20 (-2.97%)
     
  • Crude Oil

    37.38
    -2.19 (-5.53%)
     
  • Gold

    1,877.40
    -34.50 (-1.80%)
     
  • Silver

    23.42
    -1.15 (-4.66%)
     
  • EUR/USD

    1.1755
    -0.0035 (-0.2939%)
     
  • 10-Yr Bond

    0.7810
    +0.0030 (+0.39%)
     
  • Vix

    40.28
    +6.93 (+20.78%)
     
  • GBP/USD

    1.2982
    -0.0060 (-0.4570%)
     
  • USD/JPY

    104.3060
    -0.1880 (-0.1799%)
     
  • BTC-USD

    13,114.98
    -86.51 (-0.66%)
     
  • CMC Crypto 200

    258.92
    -13.77 (-5.05%)
     
  • FTSE 100

    5,582.80
    -146.19 (-2.55%)
     
  • Nikkei 225

    23,418.51
    -75.79 (-0.32%)
     

China Jo-Jo Drugstores Receives CHEO Award and Remains Top 100 Chinese Pharmaceutical Retail Company for 11 Years

·3 mins read

HANGZHOU, China, Sept. 8, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the Company received the CHEO Awards from China Health Ecology Organization ("CHEO"), marking the 11th consecutive year of being nominated on the Top 100 Chinese Drug Store Chains list.

CHEO is a Chinese health industry conference with the highest standards, the largest scale and the most influence. It has been successfully held for 13 years since 2008. As a prestigious health industry conference in China, CHEO focuses on "Cooperation, Innovation, Technology, R&D, Capital", and brings together institutions from health industry including pharmaceuticals, commerce, finance, R&D, technology, medical care, health services, insurance and other fields. CHEO is to create a global health industry conference benchmark by providing advanced ideas, facilitating information exchanges, and offering decision-making and connection support for the development of the health industry.

Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are very pleased to receive the CHEO Award again and see we rank 44th on the list of the Top 100 Chinese Drug Store Chains in 2019-2020, which is an important period for the development of the Company. Medical reform policies in China were further implemented last year, leading to drastic changes in the market structure and such changes intensified after the outbreak of the global pandemic. We have been actively adjusting our development strategies timely, and have achieved admirable results so far in 2020. Looking forward, we will maintain our market position, actively explore service channels of the health industry, and strive to promote our smart medicine diagnosis model."

About China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies. For more information about the Company, please visit http://jiuzhou360.com. The Company routinely posts important information on its website.

Forward-Looking Statements

This press release contains information about the Company's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. The Company's encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission.

For more information, please contact:

Company Contact:

Frank Zhao
Chief Financial Officer
+86-571-88077108
frank.zhao@jojodrugstores.com

Steve Liu
Investor Relations Director
steve.liu@jojodrugstores.com

Investor Relations Contact:

Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/china-jo-jo-drugstores-receives-cheo-award-and-remains-top-100-chinese-pharmaceutical-retail-company-for-11-years-301125215.html

SOURCE China Jo-Jo Drugstores, Inc.